NovoCure Ltd (NVCR): Total Liabilities
$463.86M
As of 2025-12-31
$457.10M
As of 2026-06-30
-14.8%
3-year compound annual growth
-4.2%
5-year compound annual growth
+23.4%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $463.86M | -47.3% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $880.61M | +12.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $783.63M | +4.4% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $750.48M | +2.9% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $729.00M | +26.7% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $575.46M | +119.9% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $261.66M | +15.0% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $227.53M | +50.0% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $151.73M | +8.6% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $139.74M | +147.3% | 2018-02-22, Balance as of period end |
| 2015-12-31 | $56.52M | +182.6% | 2017-02-23, Balance as of period end |
| 2014-12-31 | $20.00M | n/a | 2016-03-01, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| NovoCure Ltd (NVCR) | 2025-12-31 | $463.86M | -47.3% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $231.20M | -19.2% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $867.30M | +3.2% |
| Bioventus Inc. (BVS) | 2025-12-31 | $455.11M | -16.1% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $162.24M | +9.4% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $400.61M | +2.7% |
| Glaukos Corp (GKOS) | 2025-12-31 | $237.33M | +14.2% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $126.16M | +6.3% |
| Artivion, Inc. (AORT) | 2025-12-31 | $436.56M | -14.9% |
Compare NVCR, UFPT, IRTC, BVS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗